VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0984491
Sex: M
Age:
State: IL

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: temperature; Result Unstructured Data: Test Result:unknown

Allergies:

Symptoms: tired; dizzy/dizziness/lightheaded; chills; he is warm all of a sudden; a history of vertigo, so he thought he was having a vertigo attack; super sick on the 8th after his second dose; Fever; This is a spontaneous report from a contactable nurse (patient). A 28-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EK9231), via an unspecified route of administration on 07Jan2021 at single dose on the left arm for COVID-19 immunization. Medical history included vertigo from Aug2019. There were no concomitant medications. The patient received the vaccine through the facility where he works (not a military facility). Patient received his first dose on 17Dec2020 (lot number: EL0140). Patient said that the symptoms started Monday, he was super sick Friday after first dose. Patient clarified to super sick on 08Jan2021 after his second dose. On 08Jan2021 after his second dose, patient had a fever of unknown temperature which he slept through it. He was tired the whole day on Monday (11Jan2021) and really dizzy and had chills from then to now, which is not stopping, he means the dizziness is not better, the chills come and go. He clarifies that he did take Tylenol to treat the fever and the next day he had no fever. He says that the dizzy, he still has it. Patient took 500mg once by mouth of the Tylenol. Patient stated that he also has a history of vertigo, so he thought he was having a vertigo attack, but he took his medicine and it did not help him. Patient stated that these were not serious for him, he just feels dizzy and lightheaded. He has no loss of balance. The patient reported that he had both doses of the COVID vaccine on the left arm. Patient had the second dose on 07Jan2021, and until now he has been dizzy, it started 3 days ago (11Jan2021), he has had chills and then after he was warm all of a sudden, he was concerned. Patient has had no new medications or other vaccinations recently. He last saw his doctor six months ago and he plans to see her tomorrow (15Jan2021). The events were assessed as non-serious by the reporter. Outcome of the event dizzy/dizziness vertigo attack, and chills was not recovered (ongoing), for fever was recovered on 09Jan2021 while for other events was unknown.

Other Meds:

Current Illness:

ID: 0984492
Sex: M
Age:
State: PA

Vax Date: 01/12/2021
Onset Date: 01/15/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Inflammation and skin welts noted in areas of clothing and watch contact with skin; Inflammation and skin welts noted in areas of clothing and watch contact with skin; acute swelling of lip without trauma; This is a spontaneous report from a contactable physician, the patient. A 43-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscular in the left arm on 12Jan2021 at 09:30 (at the age of 43-years-old) as a single dose for Covid-19 immunization. Medical history was reported as none. Prior to the vaccination, that patient was not diagnosed with COVID-19. The patient did not have any known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient previously received dose 1 of BNT162B2 on 29Dec2020 at 09:30, intramuscular in the right buttocks. On 15Jan2021 at 12:00, the patient experienced inflammation and skin welts in the areas of clothing and watch contact with skin; and developed acute swelling of the lip without trauma. Therapeutic measures were not taken and the events resulted in a physician or other healthcare professional office visit. The clinical outcome of the event skin inflammation, skin welts and lip swelling was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0984493
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain and a dull ache on the same place on her neck; fleeting facial pain/pain and a dull ache on the same place on her face/pain is consistent in her face and it is a sensation of a dull ache; tingling on the right side of her face; This is a spontaneous report from a contactable pharmacist (patient) via a Pfizer sales representative. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration at the left arm on 08Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 10Jan2021, the patient noticed fleeting facial pain and tingling on the right side of her face. She awoke in the middle of the night on 13Jan2021 with pain and a dull ache on the same place on her face and neck. Today, on 15Jan2021, the pain was consistent in her face and it is a sensation of a dull ache. The outcome of the event fleeting facial pain/pain and a dull ache on the same place on her face/pain is consistent in her face and it is a sensation of a dull ache was not recovered while the outcome of the events tingling on the right side of her face and pain and a dull ache on the same place on her neck was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0984494
Sex: F
Age:
State: FL

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Name: weight; Result Unstructured Data: Test Result:150 lbs; Comments: She went from 150 pounds to 106 pounds; Test Name: weight; Result Unstructured Data: Test Result:106 lbs; Comments: She went from 150 pounds to 106 pounds

Allergies:

Symptoms: arm is hurting so bad; could not move her arm, her left arm; it feels like lead; she got the injection in is like equalizing the pain she has; hurts all over; sleeps every 2 hours; This is a spontaneous report from a contactable consumer (patient). An 89-year-old female patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date), via an unspecified route of administration on the left arm on 13Jan2021 10:35 at a single dose for COVID-19 immunization. Ongoing medical history heart failure, kidney failure, scoliosis and strained hernia (causing pain down her right leg). Other medical history includes patient gave up her car and as a result she went from 5ft 4 inches to 5ft 1 inch and went from 150 pounds to 106 pounds (stated she loves this new weight. She looks fabulous and wonderful in clothes). The patient's concomitant medications were not reported. It was reported that the patient was a retired school teacher, called about the shot, the vaccine, clarified as the COVID Vaccine. She mentioned she has a history of heart failure, kidney failure, scoliosis, and hernias. She was concerned about getting the vaccine and did not think she should get it, but her doctor informed her she should get it so she did. Since getting it she is having a hard time. Stated it feels like lead. She contacted her doctor and was informed to wait it out 24 hours and it would be a lot better. It was reported that the patient got the COVID Vaccine shot yesterday (13Jan2021 10:35). She mentioned her arm is hurting so bad. She contacted her doctor's office and was informed to give it another 24 hours for the pain to go away. It was reported that the patient hurts so bad, she hurts all over. She added she guesses the arm where she got the injection in is like equalizing the pain she has. She stated as soon as she got the injection everything was wonderful. It was afterwards she felt like she could not move her arm, her left arm. She felt like at first she was having a stroke. She did some self testing and was happy she realized she was not having a stroke. It was reported that the patient provided conflicting details of when arm hurting started. She initially stated it started 13Jan2021. She then stated she did not feel it until 8am in the morning of 14Jan2021 (pending clarification) when she could not move her arm and thought she was having a stroke. She commented she sleeps every 2 hours. She would later mention in report she felt the arm pain starting yesterday (as reported). Attempts made to clarify start of arm hurting, but unable to clarify further. She is scheduled to get the second does on 03Feb2021. She commented even with her age she is still very useful. She was told to continue taking acetaminophen. She has the 1000 mg, take two pills every six hours. She was told if she continued to have pain to take Aleve. Treatment was given for the events. The outcome of the event was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness: Heart failure (Verbatim: Heart failure); Hernia (Verbatim: Strained hernia causing pain down her right leg); Kidney failure (Verbatim: Kidney failure); Scoliosis (Verbatim: Scoliosis)

ID: 0984495
Sex: F
Age:
State: MN

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; chills; sweating; nausea; tonsil stones; muscle aches; This is a spontaneous report from a contactable other healthcare professional (reported for herself). A 26-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular (left arm) on 12Jan2021 (12:15 PM) at single dose for Covid-19 immunization. The patient received the first dose of BNT162B2 (lot number: EK9231) intramuscular (left arm) on 23Dec2020 (03:00 PM) for Covid-19 immunization. The patient's medical history included migraines and anemia; no known allergies. Concomitant medications included spironolactone, frovatriptan succinate, ethinylestradiol, norgestimate (TRI-SPRINTEC), and ferrous sulfate. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced headache, chills, sweating, nausea, tonsil stones, and muscle aches on 13Jan2021 (07:00 AM). There was no treatment received for the adverse event. The outcome of events was recovering. The patient has not been tested for COVID-19 since the vaccination.

Other Meds: SPIRONOLACTONE; FROVATRIPTAN SUCCINATE; TRI-SPRINTEC; FERROUS SULFATE

Current Illness:

ID: 0984496
Sex: F
Age:
State: OR

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; weird taste in mouth; tingling lips; feeling very cold; pain ache under armpit; neck pain; headache moving around and off and on; tingling legs; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EJ1685) via intramuscular on right arm on 17Jan2021 08:30 at single dose for COVID-19 immunisation. Medical history included depression, anxiety, attention deficit hyperactivity disorder (ADD). Concomitant medication included celecoxib (CELEXA), dexmethylphenidate hydrochloride (FOCALIN), ibuprofen, paracetamol (TYLENOL). No other vaccine in four weeks. The patient had no COVID prior vaccination. The patient had no COVID tested post vaccination. The patient previously took cefixime (FLEXERIL) and experienced drug hypersensitivity, naproxen and experienced drug hypersensitivity. On first day after vaccine the patient experienced sore arm, weird taste in mouth, tingling lips, feeling very cold, pain ache under armpit, neck pain, headache moving around and off and on, tingling legs, all on 17Jan2021 08:45. No treatment received for the events. The outcome of the events was unknown.

Other Meds: CELEXA [CELECOXIB]; FOCALIN [DEXMETHYLPHENIDATE HYDROCHLORIDE]; IBUPROFEN; TYLENOL

Current Illness:

ID: 0984497
Sex: F
Age:
State: AZ

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Numbness and tingling in left arm; Numbness and tingling in left arm; Strong pain in left forearm; Feels like she had hit her funny-bone and the effect was lasting quite a while.; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL1283) via an unspecified route of administration on the left arm on 14Jan2021 15:30 at single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. There were no concomitant medications. No other vaccine in four weeks. The patient had no COVID prior vaccination. The patient had not COVID tested post vaccination. The patient experienced numbness and tingling in left arm, strong pain in left forearm, feels like she had hit her funny-bone and the effect was lasting quite a while, all on 14Jan2021 17:00. Next day, still tingling and numbness in left arm. No treatment received for the events. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0984498
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dry mouth; numbing and tingling of left side of face /Numb on left side of neck; numbing and tingling of left side of face; numbing and tingling of left side of face and left side of upper/lower lips; numbing and tingling of left side of face and left side of upper/lower lips; This is a spontaneous report from a contactable Other Healthcare Professional (patient). A 48-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK9231), via an unspecified route of administration on 06Jan2021 at a single dose on left arm for COVID-19 immunization. Medical history included none. Patient had no known allergies. The patient's concomitant medications were not reported. The patient experienced dry mouth, numbing and tingling of left side of face and left side of upper/lower lips, numb on left side of neck on 06Jan2021. Shot was in left arm. Concerned about getting second vaccine. No treatment received in response to the events. The outcome of the events was recovering. The patient was not pregnant. Facility type vaccine was Public Health Clinic. No other vaccine in four weeks. Not diagnosed with COVID prior vaccination. Not tested for COVID post vaccination.

Other Meds:

Current Illness:

ID: 0984499
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: significant leakage from the sight of injection; This is a spontaneous report from a contactable Pharmacist. This Pharmacist reported similar events for two patients. This is 2nd of two reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, after administration of the vaccine, the pharmacist reported that two of their doctors had significant leakage from the sight of injection. This was a clear fluid leaking out of the sight of injection. The pharmacist knew this type of leaking fluid is a common occurrence with the flu vaccine, but the pharmacist wanted to ask if there is any particular guidance on what should be done in the case of this vaccine. The pharmacist asked if the doctors should get titers drawn up to determine if they need to get a 3rd dose or if they should go ahead and get the 3rd dose anyways. The outcome of the event was unknown. Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021030291 same reporter/drug/event; different patient

Other Meds:

Current Illness:

ID: 0984500
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Result Unstructured Data: Test Result:Positive for covid

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program, Pfizer First Connect. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the second of 20 reports. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984501
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the third of 20 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event tested positive for the virus (COVID-19) based on the known safety profile. However the short duration since the vaccine first dose is given it is unlikely patient would have fully developed immunity.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984502
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19 test; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine.; This is a spontaneous report from a contactable nurse. This nurse reported the same event for 20 patients (15 residents and 5 staff members). This is the fourth of 20 reports. A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, the patient has tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if the patient should receive the second dose. Information on the lot/batch number has been requested.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 03Jan2021, and tested positive for the virus (COVID-19) in Jan2021. No complete effect of the suspect vaccine could be reasonably achieved from first dose to protect from the targeted infection. Further information like COVID infection date needed for a full meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984503
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: covid-19 test; Test Result: Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse received from Pfizer sponsored program Pfizer First Connect. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the 5th of 20 reports. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information provided, the lack of efficacy cannot be excluded for vaccine BNT162B2.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984504
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: covid-19; Test Result: Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the sixth of 20 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 03Jan2021, and tested positive for the virus (COVID-19) in Jan2021. No complete effect of the suspect vaccine could be reasonably achieved from first dose to protect from the targeted infection. Further information like COVID infection date needed for a full meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984505
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: Patient tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the seventh of 20 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984506
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Covid-19 test; Test Result: Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program Pfizer First Connect. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the ninth of 20 reports. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information provided, the lack of efficacy cannot be excluded for vaccine BNT162B2. ,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984507
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Covid-19; Result Unstructured Data: Test Result:Postive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program Pfizer First Connect. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the twelfth of 20 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of suspect BNT162B2 cannot be completely excluded for reported events.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984508
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program Pfizer First Connect. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the 13th of 20 reports. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984509
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Result Unstructured Data: Test Result:tested positive

Allergies:

Symptoms: patient tested positive for the virus (COVID-19) after the first dose of the vaccine; patient tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via the Pfizer-sponsored Program. This nurse reported the same event for twenty (20) patients (15 residents and 5 staff members). This is the sixteenth (16th) of the twenty (20) reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984510
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the seventeenth of 20 reports. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be completely excluded for reported events.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984511
Sex: U
Age:
State: MA

Vax Date: 01/03/2020
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: Tested positive for covid after 1st dose received on 03Jan2021; Tested positive for covid after 1st dose received on 03Jan2021; This is a spontaneous report from a Pfizer sponsored program. A contactable nurse reported same event for 20 patients (15 residents and 5 staff members). This is the 18th of 20 reports. A patient of unspecified age and gender receive the first dose bnt162b2 (BNT162B2 also reported as Pfizer-Biontech Covid-19 Vaccine, lot/batch number and expiry date not reported), via an unspecified route of administration on 03Jan2020 at SINGLE DOSE for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient was tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. The outcome of event was unknown. Information on Lot/Batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported tested positive for the virus (COVID-19) based on the known safety profile. However the short duration since the vaccine first dose is given it is unlikely patient would have fully developed immunity.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984512
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the nineteenth of 20 reports. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be completely excluded for reported events.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984513
Sex: U
Age:
State: MA

Vax Date: 01/03/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID-19 test; Test Result: Positive

Allergies:

Symptoms: Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; Patient have tested positive for the virus (COVID-19) after the first dose of the vaccine; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program. This nurse reported same event for 20 patients (15 residents and 5 staff members). This is the 20th of 20 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 03Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, the patient have tested positive for the virus (COVID-19) after the first dose of the vaccine. The nurse wanted to confirm when and if patient should receive the second dose. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 03Jan2021, and tested positive for the virus (COVID-19) in Jan2021. No complete effect of the suspect vaccine could be reasonably achieved from first dose to protect from the targeted infection. Further information like COVID infection date needed for a full meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient

Other Meds:

Current Illness:

ID: 0984514
Sex: M
Age:
State: CA

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: COVID-19 PCR test; Test Result: Negative

Allergies:

Symptoms: He woke up twice. He initially woke up at 5 am on (14Jan2021) and that is when he experienced his legs are actually numb. He also woke up sweating; He woke up twice. He initially woke up at 5 am on (14Jan2021) and that is when he experienced his legs are actually numb. He also woke up sweating; He woke up twice. He initially woke up at 5 am on (14Jan2021) and that is when he experienced his legs are actually numb. He also woke up sweating; he fell flat on the floor; felt really tired; arm feels like it was punched by a gorilla/his arm was sore/muscle sore; arm feels like it was punched by a gorilla/his arm was sore/muscle sore; He couldn't hardly move it sore; tingling, kind of like ants crawling up his leg; This is a spontaneous from a contactable consumer (patient). A 29-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), via intramuscular route of administration on 13Jan2021 at 19:05 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took Hepatitis B vaccine that is supposed to last for 10 years (which was administered for about three years ago) and flu vaccine. On 13Jan2021, patient received the vaccine and felt really tired, his arm feels like it was punched by a gorilla, it was sore. He couldn't hardly move it sore, like a muscle sore, so he went to bed. His arm was really, really sore, he's just kind of avoided using his arm. He woke up twice. He initially woke up at 5 am on (14Jan2021) and that is when he experienced his legs are actually numb. He also woke up sweating. He didn't know his legs were numb until he literally got out of bed, and he fell flat on the floor because he could not feel them. He went to bed again and woke up at 7:20. On an unspecified date in Jan2021, he feels the tingling, kind of like ants crawling up his leg. It's not as bad as it was, it's like a feeling one gets when sitting on top of your legs. He wanted to know could these be side effects of the vaccine. The patient took Advil for arm feels like it was punched by a gorilla/his arm was sore/muscle sore. The patient underwent lab test which included COVID-19 PCR test with negative result on 10Jan2021. The outcome of the events arm feels like it was punched by a gorilla/his arm was sore/muscle sore, he couldn't hardly move it sore, numbness in leg was not recovered; sweating was recovered on an unspecified date, while unknown for the other events.

Other Meds:

Current Illness:

ID: 0984515
Sex: F
Age:
State: DC

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: Covid PCR Test (Nasal Swab); Test Result: Negative

Allergies:

Symptoms: petechiae with discoloration; petechiae with discoloration; L 2nd MTP and R 3rd MTP burning sensation; foot blister; stubbed a toe; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284) at Left arm, intramuscular on 14Jan2021 16:45 at single dose for covid-19 immunisation. Medical history included Sjogren's, Raynaud, s/p Total abdominal hysterectomy (TAH)/Bilateral salpingo-oophorectomy (BSO) sex cord sclerosing stromal tumor, and known allergies: Sulfa. Patient did not have Covid prior vaccination. Concomitant medication included hydroxychloroquine sulfate (PLAQUENIL), leflunomide, ciclosporin (RESTASIS), pilocarpine, colecalciferol (VITAMIN D), fish oil (OMEGA 3). Since the 14Jan2021 Pfizer COVID vaccine, the patient had left (L) 2nd Metatarsophalangeal (MTP) and right (R) 3rd MTP burning sensation on 15Jan2021 10:00 (like she had foot blister or stubbed a toe). Then, she had petechiae with discoloration on 16Jan2021 and 17Jan2021. No treatment was received for the events. The patient lab data included Covid PCR Test (Nasal Swab): negative on 15Jan2021. The outcome of events was recovering.

Other Meds: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; LEFLUNOMIDE; RESTASIS; PILOCARPINE; VITAMIN D [COLECALCIFEROL]; OMEGA 3 [FISH OIL]

Current Illness:

ID: 0984516
Sex: M
Age:
State: VA

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; my lighter weight facial fillers swelled and were painful (around the eyes - not my lip fillers); my lighter weight facial fillers swelled and were painful (around the eyes - not my lip fillers); numbness in both hands; This is a spontaneous report from a contactable pharmacist (patient). A 50-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK4176, expiration date not reported), intramuscular on the left arm, on 07Jan2021, at 11:30 at a single dose for Covid-19 immunization. The patient has no medical history and no known allergies . There were no concomitant medications. The patient previously took the first vaccine of bnt162b2 on 18Dec2020, at 12:00 PM, Intramuscular, on the Right arm for Covid-19 immunization, he had numbness in his right hand x2 days. On 09Jan2021, following second dose, he has had numbness in both hands x2 days and on 10Jan2021, day 2, he ran a fever and his lighter weight facial fillers swelled and were painful (around the eyes - not my lip fillers). His eyes have a mix of Juvaderm products. It spontaneously resolved after 1 day with a subjective loss in overall volume. Density of the product used seemed to be a factor in the response. He knows this has been reported with the Moderna product, but he does not believe is has been reported with our product. It appears the response may not be product specific, but more specific to the type of vaccine. The patient has no Covid prior vaccination and not covid tested post vaccination. No treatment was received for the events. Outcome of the events was recovered in Jan2020.

Other Meds:

Current Illness:

ID: 0984517
Sex: F
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Name: body aches; Result Unstructured Data: Test Result:level 7; Comments: normally; Test Date: 202101; Test Name: body aches; Result Unstructured Data: Test Result:went up to an 8.5; Test Name: headaches; Result Unstructured Data: Test Result:a level 7 or 8; Comments: normally; Test Date: 202101; Test Name: headaches; Result Unstructured Data: Test Result:increased to a level 9

Allergies:

Symptoms: body aches increased; headache worse; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration (reported as injection) in the left arm on 08Jan2021 at a single dose for COVID vaccine due to the patient's age and lives in continued care retirement community. Medical history included ongoing pain and ongoing persistent headaches, both since 2009. Concomitant medication included erenumab aooe (AIMOVIG) from an unspecified date in 2020 (started taking it 3 months ago). The patient reported side effect from the vaccine received on 08Jan2021. She has had body aches and headaches since 2009, so she figured after reading about the side effects, she would probably have worse body and headaches, but the body aches lasted maybe 4-5 days, from the time of vaccination, she has what was called new daily persistent headaches, which was a rare form of headache. They didn't have meds for it, because not many people have it, it was not a money maker to try to find something that works. She figured this would make headache worse and that was what it did, they were normally a level 7 or 8 on an unspecified date, and they increased to a level 9 on Jan2021, and she couldn't find a way to get it back down. The patient called her headache specialist and she thought steroid injections might help but wanted her to talk to someone to let them know the side effect the patient was having, with the headaches. Her body aches never go away, headaches never go away, and the day of the vaccine, she still had them both as normal, but after receiving the vaccine, her body aches increased, they went up a level, they were normally, a level 7 on an unspecified date, and after the vaccine, they went up to an 8.5 on Jan2021. She took Tylenol, regularly, every 4 to 6 hours, and after about 4 days, the body aches were down to the normal ache. But, the headache did not. The headache was starting to get worse. The outcome of the event body aches increased was recovering while the other event was not recovered. Information on the lot/batch number has been requested.

Other Meds: AIMOVIG

Current Illness: General body pain; Persistent headache

ID: 0984518
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date: 01/15/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; fatigue; sore arm; breathing problems when she is walking fast.; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of unspecified age received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration on 13Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 15Jan2021, at the time of report, the patient experienced headache, major fatigue, sore arm and breathing problems when she is walking fast. She was told to sit down and report the issues according to the instructions provided to her. She said she was going to do that when she got home and will rest up for the day. She did not sound winded when and had good speech. She calmed down and she was ok. Outcome of the events was unknown. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0984519
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hot flashes; This is a spontaneous report based on the information received by Pfizer from a contactable consumer. A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech Covid-19 vaccine) via an unspecified route of administration at a single dose on 29Dec2020 for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 29Dec2020, it was reported that the patient received the COVID vaccine "yesterday" and was having hot flashes that went away after 2 hours. Event onset date was unknown. The event resolved on an unspecified date. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0984520
Sex: F
Age:
State: VA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Body temperature; Result Unstructured Data: Test Result:100 f Fahrenheit; Test Date: 20210108; Test Name: Body temperature; Result Unstructured Data: Test Result:101.3f Fahrenheit; Test Date: 202101; Test Name: Body temperature; Result Unstructured Data: Test Result:100-99.5f Fahrenheit; Comments: 100-99.5f another 8hrs; Test Date: 202101; Test Name: Body temperature; Result Unstructured Data: Test Result:101.5f to 100 f Fahrenheit; Comments: 101.5f to 100 f 24hrs

Allergies:

Symptoms: my temperature was 101.5f to 100 f 24hrs. and 100-99.5f neck and head heaviness another 8hrs; neck to shoulder, chill; head heaviness; neck and head heaviness another 8hrs; still felt the pain on the injection site but not too much; fatigue; shoulder pain; sleepy; sleepy; This is a spontaneous report from a contactable nurse (patient). A 50-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK4176), via an unspecified route of administration on 08Jan2021 11:00, at left arm, at single dose for covid-19 immunization. Medical history included Hx of hypothyroidism. not now, known allergies was none. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK5730), via an unspecified route of administration on 18Dec2020 14:00, at left arm, at single dose for covid-19 immunization and after the first dose, the patient had a pain from left side neck to elbow at next day but it was gone, she felt little sleepy the day she got vaccine. The patient received the second dose on 08Jan2021, and the patient was little sleepy so she went to sleep 8pm (20:00), from 11pm (23:00) 100f she woke up due to neck to shoulder, chill, 11:30pm (23:30) 101.3f after that she had same symptoms and her temperature was 101.5f to 100 f 24hrs, and 100-99.5f neck and head heaviness another 8hrs, she took Advil 200mg x4 in the 32hrs. She still felt the pain on the injection site but not too much. She went back to work 12Jan2021 but feel fatigue until yesterday (16Jan2021) but no more shoulder pain. No treatment was received for all events except fever. The outcome of the event fatigue was not recovered, the outcome of the event pain on the injection site was recovering, the outcome of the other events was recovered in Jan2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.

Other Meds:

Current Illness:

ID: 0984521
Sex: F
Age:
State: NJ

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: Temperature; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: Dizzy; Symptoms included temperature; Sweating; Chills; Headache; Stomach ache; Weakness; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 13Jan2021 at 11:00, at a single dose, for COVID-19 immunization. The patient's medical and concomitant medications were not reported. On 13Jan2021 at 11:00 AM, the patient had a human exposure from the COVID-19 vaccine. The patient received the COVID-19 vaccine on Wednesday at 11 AM. On 13Jan2021 at 11 AM, the following symptoms included temperature, sweating, chills, headache, stomach ache, weakness, and dizzy. The following first aid measures have been taken. The patient went to the emergency room last night where they advised her to self-quarantine. The outcome of the events was unknown. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 0984522
Sex: F
Age:
State: MI

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Intestinal cramps; urgency to go to the bathroom/the urgency is almost like diarrhea; nausea; sore arm; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored Program. A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231, expiration date 30Apr2021) on her left deltoid, intramuscular on 14Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported by the patient that she is having intestinal cramps since last night. The patient also said that she is also experiencing nausea, urgency to go to the bathroom (the urgency is most likely diarrhea), and she has a sore arm; all on 14Jan2021. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0984523
Sex: M
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; This is a spontaneous report from two contactable physicians (patient) via Pfizer Sales Representative. Both physicians reported same event for 2 patients. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. It was reported patient had a sore arm. The two physicians both had the vaccine at the same time. The adverse event took place after Pfizer Product use. Outcome of the event was unknown. Information on lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021044462 same reporter/drug, different patient/event

Other Meds:

Current Illness:

ID: 0984524
Sex: F
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; This is a spontaneous report from two contactable physicians (patient) via Pfizer Sales Representative. Both physicians reported same event for 2 patients. This is second of 2 report. A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. It was reported patient had a sore arm. The two physicians both had the vaccine at the same time. The adverse event took place after Pfizer Product use. Outcome of the event was unknown. Information on lot/batch number has been requested. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021044461 same product/AE/ reporter, different patient

Other Meds:

Current Illness:

ID: 0984525
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; chills; malaise; body aches; This is a spontaneous report from a contactable nurse (patient). A female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified at a single dose for COVID-19 immunization. Medical history included covid-19 on summer of 2020. The patient's concomitant medications were not reported. The patient experienced fever, chills, malaise, and body aches the day after receiving the Covid vaccine. The symptoms were such that patient had to leave work at 1pm and the "fever" broke at 5:30 after taking Motrin. Outcome of the event fever was recovered, while for the remaining events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0984526
Sex: F
Age:
State: OR

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Fatigue; localized muscle soreness at injection site; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot and expiry not reported), via an unspecified route of administration on 14Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced headache, fatigue, localized muscle soreness at injection site on an unspecified date, which are general post-vaccine symptoms. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0984527
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: eyelids are a little swollen; This is spontaneous report from a contactable consumer. An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, "Pfizer vaccine" as reported, lot number: unknown), via an unspecified route of administration on an unspecified date (06:30AM) at single dose for Covid-19 immunization. The patient's medical history included allergy to antibiotics (reported as "she is allergic to other things, but they are antibiotics"). Concomitant medications were not reported. The patient reported that she had the vaccine at 6:30AM (unspecified date) which she thought was Moderna (pending clarification). She clarified that she was supposed to get Pfizer's but that she thought that she was allergic to some of things in it (pending clarification). She further stated that her eyelids are a little swollen on an unspecified date. She did not know if she should take Benadryl or what. She reported that she was having slight reaction to the shot. She stated that she is allergic to other things, but they are antibiotics. The outcome of event was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0984528
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: one woman has been breastfeeding; early menses after receiving the vaccine; This is a spontaneous report from a Pfizer sponsored program, from a contactable consumer. This consumer reported information for both mother and baby. This is the maternal report. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. Medical history included "has not had a period since 2019". The patient's concomitant medications were not reported. The patient had early menses after receiving the vaccine. She has been breastfeeding. Outcome of the event "early menses after receiving the vaccine" was unknown. Information on lot number/batch number was requested.

Other Meds:

Current Illness:

ID: 0984529
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no longer has periods due to hormone therapy got a period a few days after receiving the vaccine; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer that a female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included that patient had no longer has periods due to hormone therapy since an unknown date and unknow if ongoing. The patient's concomitant medications were not reported. This patient has no longer has periods due to hormone therapy got a period a few days after receiving the vaccine on an unknown date. The outcome of the event "no longer has periods due to hormone therapy got a period a few days after receiving the vaccine" was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0984530
Sex: M
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: Covid test; Test Result: Negative ; Comments: 98% accurate Covid test

Allergies:

Symptoms: Chills; Fever; very lethargic; a lot of aches and pains; Exhaustion; This is a spontaneous report from a contactable consumer (patient's wife). A 75-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot number: EL1283, expiration date: Apr2021), intramuscularly on the right arm (also reported as upper right arm) on 11Jan2021 at 10:15 at a single dose for COVID-19 immunization administered at the hospital (medical center). The patient had no medical history. There were no concomitant medications. The patient had no history of previous immunization with the Pfizer vaccine. The patient had no prior vaccinations within 4 weeks. He had no adverse events following prior vaccinations. He had never had a flu shot. The patient had the shot on Monday, 11Jan2021 and that early evening, he got chills, fever, and since then he had been very lethargic and had a lot of aches and pain and exhaustion. He had difficulty getting up in the morning. He just felt exhausted. She had him go have a Covid test on 12Jan2021 in the late afternoon to make sure he did not have Covid; he took the test that was a 98% accurate Covid test, and it was negative. The reporter was asking if that was a common reaction or if the patient had some type of virus. The reporter was asking if the patient should get the second shot. The patient experienced the chills at night, the day he received the vaccine and by the next morning they were gone. The reporter stated that the patient was still exhausted and lethargic. He was normally a very active person and now he was down and out. The events did not require a visit to the emergency room or the physician office. The patient did not receive any treatment for the events. The patient recovered from the events "chills and fever" on 12Jan2021. The patient was not recovered from the events "very lethargic, a lot of aches and pains, and exhaustion."

Other Meds:

Current Illness:

ID: 0984531
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lower extremity joint pain; Nerve pain; Fatigue; This is a spontaneous report from a contactable Pharmacist via a Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced lower extremity joint pain and nerve pain along with fatigue after receiving the Pfizer/BioNTech vaccine. Symptoms started at 3 am, the morning after the vaccine was administered and persisted until 5 pm that day. Outcome of the events was unknown. No follow-up attempts are possible. Information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0984532
Sex: F
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness in arm; Body aches; This is a spontaneous report received from a contactable (patient) via a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, on 15Jan2021, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced soreness in arm and body aches on 15Jan2021. The patient wanted to know if she can take Tylenol or ibuprofen. The outcome of the events was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0984534
Sex: M
Age:
State: CO

Vax Date: 01/14/2021
Onset Date: 01/01/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: body aches; muscle pain; joint pain; headache; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received his first dose of bnt162b2 (BNT162B2 also reported as Covid-19 Vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration on 14Jan2021 at single dose, for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced body aches, muscle pain, joint pain and headache on Jan2021. The outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0984535
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Has been a little sleepy; Swollen stomach; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that her husband (patient) seems fine but has been a little sleepy and has a swollen stomach on an unspecified date. The outcome of the events was unknown. Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0984536
Sex: M
Age:
State: CO

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: injection site pain to right arm; Chills; Headache; light fever; This is a spontaneous report from a contactable consumer. A 78-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ELL742) on his right arm, via an unspecified route of administration on 14Jan2021 07:00 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient got injection site pain to right arm, chills, headache and a light fever; all on 14Jan2021 19:00. It was also stated that the injection site pain was severe and is now less. Also reported that the patient recovered from the chills during the night completely. The patient took a couple of aspirin last night and will take some more this morning as treatment. The outcome of the event chills was recovered on 14Jan2021, not recovered for event light fever while recovering for the remaining events.

Other Meds:

Current Illness:

ID: 0984537
Sex: M
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: slightly sore arm where the needle went in; This is a spontaneous report from a contactable pharmacist via a Pfizer sales representative. A male patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration in the arm on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the Pfizer COVID vaccine 8 days ago and had no side effects other than a slightly sore arm where the needle went in on 07Jan2021. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0984538
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: experiencing a scratchy throat; runny nose; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's husband) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's husband stated that his wife (patient) experiencing a scratchy throat and runny nose after the first dose. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0984539
Sex: F
Age:
State: NY

Vax Date: 12/23/2020
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Her arm killed her and was painful for two days, she could barely move her arm; Her arm killed her and was painful for two days, she could barely move her arm; She also experienced numbness in her face, jaw, cheeks, mouth that lasted for about 3 hours; She also experienced numbness in her face, jaw, cheeks, mouth that lasted for about 3 hours; This is a spontaneous report from a contactable nurse. A 51-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization. Medical history included ongoing asthma for approximately 25 years ago. There were no concomitant medications. After she took the first dose, on an unknown date, her arm killed her and was painful for two days, she could barely move her arm. She also had numbness in her mouth, face, jaws, and cheeks that lasted about 3 hours. The outcome of the events was unknown.

Other Meds:

Current Illness: Asthmatic (Verbatim: Asthmatic/Additional Information for Other Conditions: approximately 25 years ago)

ID: 0984540
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tired; achy; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine two weeks ago on an unspecified date. On an unspecified date, he was achy and tired and was wondering if this was normal. The outcome of the events pain and fatigue was unknown. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0984541
Sex: F
Age:
State: SC

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 01/29/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dark coloration in urine; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, lot number and expiration date not provided), via an unspecified route of administration on 16Jan2021 at a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included unspecified drugs. The patient got the 1st dose of Covid 19 Vaccine yesterday and experienced side effects on 17Jan2021). The patient reported dark coloration in urine, but it's not blood and it's like dark coffee color or dark rust in color, slightly red, but the next morning it's gone. The patient was worrying and wanted to know more information. She also added, maybe it's just in the other medication that she is taking. The patient recovered from the event on 18Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm